In keeping with this hypothesis, we found that OPG, which acts as a decoy receptor for RANK, inhibited RANKL-induced osteoclast formation and that an antibody to TNF-α inhibited osteoclast formation associated with the production of a soluble factor by Ewing's sarcoma cells. The gene discussed is TNFRSF11A; the disease is Ewing sarcoma.